NICE Type 2 Diabetes Guidelines Updated — But Significant Issues Remain
The latest update to the NICE Type 2 Diabetes management guidelines (NG28) has now been published. While this update had been anticipated as an opportunity to address long-standing concerns around lifestyle advice and patient choice, the final guidance falls short of expectations and leaves major issues unresolved.
Over the past year, X-PERT Health, alongside partner organisations, has been actively engaging with NICE to highlight critical limitations in the existing guidelines. These include the lack of support for type 2 diabetes remission as a realistic goal, insufficient recognition of different evidence-based dietary approaches, and a failure to adequately prioritise informed, patient-centred choice.
Earlier correspondence from NICE had suggested that these concerns would be considered as part of an ongoing update to NG28. However, despite stakeholder submissions and detailed feedback on the draft guidance, the final version of the update does not introduce any meaningful changes in relation to these issues. Many of the points raised were deemed “out of scope”, despite their clear relevance to patient care and consistency with other NICE guidelines.
In a new blog, Dr Sean Wheatley, Science and Research Lead at X-PERT Health, provides a clear and accessible overview of:
– Why changes to the guidelines are urgently needed
– What has happened throughout the update process
– Why the outcome is so disappointing
– And what potential next steps still offer cautious optimism for future change
While this represents another missed opportunity to modernise type 2 diabetes guidance in line with current evidence, there are still avenues being pursued — including further engagement with NICE and the NICE surveillance process — that may yet lead to a more comprehensive review.
Read the full blog to understand what this update means, why it matters, and how efforts to improve guidance for people living with type 2 diabetes will continue.
👉 Read the blog: NICE Type 2 Diabetes Management Guidelines – Big Disappointments and Major Issues
